The Ahmedabad-based siblings behind the Torrent Group have taken a bet that could change the shape of India’s pharmaceutical sector. Riding on India’s ambition to become the “world’s pharmacy, ” brothers Sudhir and Samir Mehta, who ranked No. 15 on the Forbes India Rich List 2025 with a net worth of $14.1 billion, have just taken a major step that could reshape their empire’s future.

The $1.3 billion power move

In June 2025, Torrent Pharmaceuticals, the flagship company of the Mehta brothers, agreed to buy KKR’s 46% stake in rival JB Chemicals & Pharmaceuticals for ₹11,900 crore ($1.3 billion), according to Forbes. The deal values JB Pharma at around $3 billion, which instantly makes this step one of the biggest takeovers in India’s pharma space this year.

Soon after, Torrent launched

See Full Page